Filing Flows

Filing Flows › BioStem Technologies (BSEM) › Next earnings date

BioStem Technologies (BSEM) earnings on Nov 12, 2026: what to expect

BioStem Technologies (BSEM) is expected to report earnings on Nov 12, 2026, in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.43 (1 estimate) on revenue of $7.2M. It beat the EPS estimate in 0% of the quarters on record; Filing Flows' model gives it a 59% chance of beating next time.

Report dateNov 12, 2026
Days to go4
EPS estimate−$0.43
Revenue estimate$7.2M
Beat rate0%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

BioStem Technologies: revenue lines, growth year over year, Q2 2026BioStem Technologies: revenue lines, growth year over year, Q2 2026Revenue-28%Physician Office-90%

The last report

BioStem Technologies reported revenue of $7.9M for the second quarter 2026 (-28% Y/Y), net loss $9.0M: Hospital $6.7M, Physician Office $1.1M, Other $89K. How it makes money → · Every quarter →

BioStem Technologies: EPS against the estimate, last 3 reportsBioStem Technologies: EPS against the estimate, last 3 reportsEstimateReported$0.00$0.06Nov 25−$0.28−$0.52May 26−$0.50−$0.52Aug 26
Latest (Aug 26): Estimate −$0.50, Reported −$0.52.

BioStem Technologies' latest quarter

BioStem Technologies, Q2 2026: revenue $7.9M (-28% year over year), operating margin -106.3%, net loss $9.0M. The chart follows the revenue to costs, profit and cash.

Questions

When does BSEM report earnings?

BioStem Technologies is expected to report on Nov 12, 2026.

What are analysts expecting from BioStem Technologies?

EPS of −$0.43 and revenue of $7.2M for the quarter.

Does BioStem Technologies usually beat earnings?

It beat the consensus EPS estimate in 0% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.